ABBOTT LABORATORIES Proceeds from Stock Issuance 2007-2026 | ABT
Beta
What is ABBOTT LABORATORIES's current proceeds from stock issuance?
ABBOTT LABORATORIES (ABT) annual proceeds from stock issuance for 2025 was $396.0M, a 50.00% increase from 2024. ABBOTT LABORATORIES proceeds from stock issuance for the quarter ending March 31, 2026 was $116.0M.
What was ABBOTT LABORATORIES's proceeds from stock issuance in 2024?
ABBOTT LABORATORIES annual proceeds from stock issuance for 2024 was $264.0M, a 58.08% increase from 2023.
What was ABBOTT LABORATORIES's proceeds from stock issuance in 2023?
ABBOTT LABORATORIES annual proceeds from stock issuance for 2023 was $167.0M, a 0.00% increase from 2022.
What is ABBOTT LABORATORIES's 5-year proceeds from stock issuance CAGR?
ABBOTT LABORATORIES proceeds from stock issuance grew at a compound annual growth rate (CAGR) of 10.08% from FY2020 to FY2025, going from $245.0M to $396.0M over 5 years.
Proceeds from Stock Issuance History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+10.1%
FY2020
$245.0M
→
FY2025
$396.0M
07080910111213141516171819202122232425
5 years selected
Proceeds from Stock Issuance History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $396.0M | +50.0% | 10-K |
| FY2024 | $264.0M | +58.1% | 10-K |
| FY2023 | $167.0M | +0.0% | 10-K |
| FY2022 | $167.0M | -34.5% | 10-K |
| FY2021 | $255.0M | +4.1% | 10-K |
| FY2020 | $245.0M | -17.8% | 10-K |
| FY2019 | $298.0M | +10.0% | 10-K |
| FY2018 | $271.0M | -22.6% | 10-K |
| FY2017 | $350.0M | +41.1% | 10-K |
| FY2016 | $248.0M | -21.0% | 10-K |
| FY2015 | $314.0M | -26.8% | 10-K |
| FY2014 | $429.0M | +8.6% | 10-K |
| FY2013 | $395.0M | -78.6% | 10-K |
| FY2012 | $1.85B | +90.9% | 10-K |
| FY2011 | $969.0M | +195.1% | 10-K |
| FY2010 | $328.4M | -35.4% | 10-K |
| FY2009 | $508.7M | -49.6% | 10-K |
| FY2008 | $1.01B | -19.3% | 10-K |
| FY2007 | $1.25B | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →